Joel T. Braslow, MD, PhD; John S. Brekke, PhD; Jeremy Levenson, BA
doi : 10.1001/jamapsychiatry.2020.2722
JAMA Psychiatry. 2021;78(4):349-350
This Viewpoint proposes that psychiatry should more closely attend to the poverty, justice system involvement, and housing issues of people with serious mental illness, supporting this view with quotes from philosophers.
Ravi N. Shah, MD, MBA; Obianuju O. Berry, MD, MPH
doi : 10.1001/jamapsychiatry.2020.2847
JAMA Psychiatry. 2021;78(4):351-352
This Viewpoint discusses potential concerns and benefits related to increasing use of applications for mental health care created by venture capital–backed companies.
Teodor T. Postolache, MD; Michael E. Benros, MD, PhD; Lisa A. Brenner, PhD
doi : 10.1001/jamapsychiatry.2020.2795
JAMA Psychiatry. 2021;78(4):353-354
This Viewpoint discusses targetable biological mechanisms implicated in emergent psychiatric conditions associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Andrew D. Carlo, MD, MPH; Brian S. Barnett, MD; Jürgen Unützer, MD, MPH
doi : 10.1001/jamapsychiatry.2020.3216
JAMA Psychiatry. 2021;78(4):355-356
This Viewpoint discusses the need for collaborative care among health care professionals to meet mental health demands in the COVID-19 pandemic.
Carlos Blanco, MD, PhD; Wilson M. Compton, MD, MPE; Nora D. Volkow, MD
doi : 10.1001/jamapsychiatry.2020.3177
JAMA Psychiatry. 2021;78(4):357-358
This Viewpoint assesses the different ways treatment and research on psychiatric disorders have shifted because of coronavirus disease 2019 (COVID-19) and suggests what changes should remain after the pandemic.
Johan Ormel, PhD; Michael VonKorff, ScD
doi : 10.1001/jamapsychiatry.2020.3443
JAMA Psychiatry. 2021;78(4):359-360
This Viewpoint discusses the need for a paradigm shift in the prevention and evaluation of common mental disorders to lower prevalence on a population basis.
Eirini Karyotaki, PhD; Orestis Efthimiou, PhD; Clara Miguel, MSc; et al.
doi : 10.1001/jamapsychiatry.2020.4364
JAMA Psychiatry. 2021;78(4):361-371
This meta-analysis provides personalized estimates of short-term and long-term relative efficacy of guided and unguided internet-based cognitive behavioral therapy for depression using patient-level information.
Kristin M. Holland, PhD, MPH; Christopher Jones, PharmD, DrPH, MPH; Alana M. Vivolo-Kantor, PhD, MPH; et al.
doi : 10.1001/jamapsychiatry.2020.4402
JAMA Psychiatry. 2021;78(4):372-379
This cross-sectional analysis uses data from the Centers for Disease Control and Prevention to examine changes in US emergency department visits for mental health, suicide attempts, overdose, and violence outcomes during the COVID-19 pandemic.
Katlyn Nemani, MD; Chenxiang Li, PhD; Mark Olfson, MD, MPH; et al.
doi : 10.1001/jamapsychiatry.2020.4442
JAMA Psychiatry. 2021;78(4):380-386
This cohort study examines the incidence of mortality in patients with COVID-19 who had premorbid diagnoses of schizophrenia spectrum, mood, or anxiety diagnoses.
Esben Agerbo, DrMedSc; Betina B. Trabjerg, MSc; Anders D. B?rglum, PhD; et al.
doi : 10.1001/jamapsychiatry.2020.4172
JAMA Psychiatry. 2021;78(4):387-397
This case-cohort study assesses the individual and joint associations of polygenic risk scores, parental history, and socioeconomic status with relative and absolute risks of early-onset depression.
?ngel Garc?a de la Garza, BA; Carlos Blanco, MD, PhD; Mark Olfson, MD, MPH; et al.
doi : 10.1001/jamapsychiatry.2020.4165
JAMA Psychiatry. 2021;78(4):398-406
This study evaluates future suicide attempt risk factors in the general population using a data-driven machine learning approach that includes more than 2500 questions from a large, nationally representative survey of US adults.
Qingyu Zhao, PhD; Edith V. Sullivan, PhD; Nicolas Honnorat, PhD; et al.
doi : 10.1001/jamapsychiatry.2020.4064
JAMA Psychiatry. 2021;78(4):407-415
This case-control study uses data from the National Consortium on Alcohol and Neurodevelopment in Adolescence cohort to investigate whether heavy alcohol drinking among adolescents is associated with microstructural brain changes.
Benjamin I. Perry, MRCPsych; Jan Stochl, PhD; Rachel Upthegrove, PhD; et al.
doi : 10.1001/jamapsychiatry.2020.4180
JAMA Psychiatry. 2021;78(4):416-425
This cohort study examines changes in fasting insulin levels and body mass index from childhood to age 24 years and the risk for psychiatric disorders in that cohort at age 24 years.
Angel Gabriel, MHS; Hossein Zare, PhD, MS; Wehmah Jones, PhD; et al.
doi : 10.1001/jamapsychiatry.2020.4622
JAMA Psychiatry. 2021;78(4):426-432
This secondary analysis of a randomized clinical trial evaluates the prevalence of depressive symptoms among low-socioeconomic-status African American women aged 40 to 75 years with uncontrolled hypertension.
Christine Moutier, MD
doi : 10.1001/jamapsychiatry.2020.3746
JAMA Psychiatry. 2021;78(4):433-438
This Special Communication discusses what data and recent events during the first 6 months of the coronavirus disease 2019 pandemic reveal about specific effects on suicide risk and outlines actionable steps that policy makers, health care leaders, and organizational leaders can take to mitigate suicide risk during and after the pandemic.
Kathleen T. Watson, PhD; Julia F. Simard, ScD; Victor W. Henderson, MD, MS; et al.
doi : 10.1001/jamapsychiatry.2020.3669
JAMA Psychiatry. 2021;78(4):439-441
This study investigates whether insulin resistance was positively associated with the presence, severity, or chronicity of major depression.
Sergi Papiol, PhD; Andrea Schmitt, MD; Isabel Maurus, MD; et al.
doi : 10.1001/jamapsychiatry.2020.3946
JAMA Psychiatry. 2021;78(4):441-444
This mendelian randomization analyzes the potential causality between physical activity and schizophrenia.
Michael Johnathan Charles Bray, MS; Nicholas Omid Daneshvari, BA; Indu Radhakrishnan, BA; et al.
doi : 10.1001/jamapsychiatry.2020.3938
JAMA Psychiatry. 2021;78(4):444-447
This cross-sectional study analyzes trends in suicidality by race/ethnicity during the coronavirus disease 2019 (COVID-19) pandemic.
Konstantinos N. Fountoulakis, MD; Mauricio Tohen, MD, DrPH, MBA
doi : 10.1001/jamapsychiatry.2020.4412
JAMA Psychiatry. 2021;78(4):447-448
Co Co Tong, MSc; Rebecca Strawbridge, PhD; Sameer Jauhar, PhD
doi : 10.1001/jamapsychiatry.2020.4418
JAMA Psychiatry. 2021;78(4):448
David J. Miklowitz, PhD; Toshi A. Furukawa, MD, PhD; Andrea Cipriani, MD, PhD
doi : 10.1001/jamapsychiatry.2020.4424
JAMA Psychiatry. 2021;78(4):448-449
doi : 10.1001/jamapsychiatry.2021.0127
JAMA Psychiatry. 2021;78(4):449
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟